CELATOR PHARMACEUTICALS INC - COM (CPXX)

CUSIP: 15089R102

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / COM
Total 13F shares
4,438,825
Share change
+1,198,245
Total reported value
$7,811,000
Price per share
$1.76
Number of holders
21
Value change
+$2,114,545
Number of buys
12
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 15089R102?
CUSIP 15089R102 identifies CPXX - CELATOR PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CELATOR PHARMACEUTICALS INC - COM (CPXX) as of Q4 2015

As of 31 Dec 2015, CELATOR PHARMACEUTICALS INC - COM (CPXX) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,438,825 shares. The largest 10 holders included CAXTON CORP, First Eagle Investment Management, LLC, VANGUARD GROUP INC, SABBY MANAGEMENT, LLC, BANK OF AMERICA CORP /DE/, NEXTHERA CAPITAL LP, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, BlackRock Institutional Trust Company, N.A., GEODE CAPITAL MANAGEMENT, LLC, and BlackRock Fund Advisors. This page lists 21 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.